273 related articles for article (PubMed ID: 36675337)
1. Using Circulating Tumor DNA as a Novel Biomarker to Screen and Diagnose Colorectal Cancer: A Meta-Analysis.
Min L; Chen J; Yu M; Liu D
J Clin Med; 2023 Jan; 12(2):. PubMed ID: 36675337
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic performance of circulating tumor DNA as a minimally invasive biomarker for hepatocellular carcinoma: a systematic review and meta-analysis.
Li JJ; Lv Y; Ji H
PeerJ; 2022; 10():e14303. PubMed ID: 36348665
[TBL] [Abstract][Full Text] [Related]
3. Using circulating tumor DNA as a novel biomarker to screen and diagnose hepatocellular carcinoma: A systematic review and meta-analysis.
Zhang Z; Chen P; Xie H; Cao P
Cancer Med; 2020 Feb; 9(4):1349-1364. PubMed ID: 31876977
[TBL] [Abstract][Full Text] [Related]
4. The diagnostic value of circulating tumor DNA in hepatitis B virus induced hepatocellular carcinoma: a systematic review and meta-analysis.
Chang Y; Jeong SW; Jang JY; Eun H; Lee YS; Song DS; Yu SJ; Lee SH; Kim W; Lee HW; Kim SG; Ryu S; Park S
J Liver Cancer; 2022 Sep; 22(2):167-177. PubMed ID: 37383408
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of circulating cell-free DNA for renal cell carcinoma: a meta-analysis.
Li Y; Chen P; Chen Z
Transl Cancer Res; 2021 May; 10(5):2265-2276. PubMed ID: 35116544
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Assessment of septin9 DNA Methylation for Colorectal Cancer Using Blood Detection: A Meta-Analysis.
Sun G; Meng J; Duan H; Zhang D; Tang Y
Pathol Oncol Res; 2019 Oct; 25(4):1525-1534. PubMed ID: 30488278
[TBL] [Abstract][Full Text] [Related]
7. Utilizing circulating tumour DNA as a prognostic predictor of gastric cancer: a meta-analysis.
Min L; Chen J; Yu M; Yang K; Liu D
Biomarkers; 2023 Dec; 28(5):427-436. PubMed ID: 37036017
[No Abstract] [Full Text] [Related]
8. The value of circulation tumor DNA in predicting postoperative recurrence of colorectal cancer: a meta-analysis.
Wang R; Zhao A; Cao N; Li Z; Zhang G; Liu F
Int J Colorectal Dis; 2020 Aug; 35(8):1463-1475. PubMed ID: 32572601
[TBL] [Abstract][Full Text] [Related]
9. Cell-Free DNA as a Diagnostic Blood-Based Biomarker for Colorectal Cancer: A Systematic Review.
Petit J; Carroll G; Gould T; Pockney P; Dun M; Scott RJ
J Surg Res; 2019 Apr; 236():184-197. PubMed ID: 30694754
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of circulating tumor DNA for detection of KRAS gene mutations in colorectal cancer patients: a meta-analysis.
Hao YX; Fu Q; Guo YY; Ye M; Zhao HX; Wang Q; Peng XM; Li QW; Wang RL; Xiao WH
Onco Targets Ther; 2017; 10():945-953. PubMed ID: 28243130
[TBL] [Abstract][Full Text] [Related]
11. The diagnostic value of circulating tumor cells and ctDNA for gene mutations in lung cancer.
Lyu M; Zhou J; Ning K; Ying B
Onco Targets Ther; 2019; 12():2539-2552. PubMed ID: 31040697
[TBL] [Abstract][Full Text] [Related]
12. The diagnostic accuracy of
Galvano A; Castellana L; Gristina V; La Mantia M; Insalaco L; Barraco N; Perez A; Cutaia S; Calò V; Bazan Russo TD; Francini E; Incorvaia L; Mirisola MG; Vieni S; Rolfo C; Bazan V; Russo A
Ther Adv Med Oncol; 2022; 14():17588359221110162. PubMed ID: 36188485
[TBL] [Abstract][Full Text] [Related]
13. Circulating Tumor DNA, Imaging, and Carcinoembryonic Antigen: Comparison of Surveillance Strategies Among Patients Who Underwent Resection of Colorectal Cancer-A Systematic Review and Meta-analysis.
Dawood ZS; Alaimo L; Lima HA; Moazzam Z; Shaikh C; Ahmed AS; Munir MM; Endo Y; Pawlik TM
Ann Surg Oncol; 2023 Jan; 30(1):259-274. PubMed ID: 36219278
[TBL] [Abstract][Full Text] [Related]
14. Circulating tumor DNA is effective for detection of KRAS mutation in colorectal cancer: a meta-analysis.
Tang M; Deng Z; Li B; Peng Y; Song M; Liu J
Int J Biol Markers; 2017 Oct; 32(4):e421-e427. PubMed ID: 28885658
[TBL] [Abstract][Full Text] [Related]
15. Detection of microRNA-21 expression as a potential screening biomarker for colorectal cancer: a meta-analysis.
Jiang JX; Zhang N; Liu ZM; Wang YY
Asian Pac J Cancer Prev; 2014; 15(18):7583-8. PubMed ID: 25292032
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Value of Methylated Septin9 for Colorectal Cancer Screening: A Meta-Analysis.
Yan S; Liu Z; Yu S; Bao Y
Med Sci Monit; 2016 Sep; 22():3409-3418. PubMed ID: 27665580
[TBL] [Abstract][Full Text] [Related]
17. The Application Value of Syndecan-2 Gene Methylation for Colorectal Cancer Diagnosis: A Clinical Study and Meta-Analyses.
Yue C; Zhang Y; Wang Y; Zhang Z; Zhang M; Wang H; Chen W; Shang Z; Xin Y; Zhang X; Zhang Y
Front Med (Lausanne); 2022; 9():753545. PubMed ID: 35372441
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of stool DNA testing for multiple markers of colorectal cancer and advanced adenoma: a meta-analysis.
Yang H; Xia BQ; Jiang B; Wang G; Yang YP; Chen H; Li BS; Xu AG; Huang YB; Wang XY
Can J Gastroenterol; 2013 Aug; 27(8):467-75. PubMed ID: 23936877
[TBL] [Abstract][Full Text] [Related]
19. Association of Circulating Tumor DNA With Disease-Free Survival in Breast Cancer: A Systematic Review and Meta-analysis.
Cullinane C; Fleming C; O'Leary DP; Hassan F; Kelly L; O'Sullivan MJ; Corrigan MA; Redmond HP
JAMA Netw Open; 2020 Nov; 3(11):e2026921. PubMed ID: 33211112
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
